Minimally invasive epilepsy surgery is an advancement that allows treatment of epilepsies that are in close proximity to the eloquent cortex, with minimal morbidity. This treatment option is relatively new in the UK.
This webinar will teach the multidisciplinary evaluation of these difficult cases, including MRI negative epilepsies and the role of Flourodeoxyglucose Positron Emission Tomography (FDG PET) and Stereoelectroencephelography (SEEG). Surgical approaches including thermocoagulation of the insula, hypothalamic hamartoma and other lesions close to the eloquent cortex will be discussed.
Speakers will enlighten doctors, consultants, and allied healthcare professionals involved in the care of patients with epilepsy, regarding exciting advances in the treatment of surgically difficult patients with refractory epilepsy.
During this webinar you will learn about:
- The severity, presentation, and evaluation of patients with refractory epilepsy that can be considered for minimally invasive surgery
- How to evaluate such patients, including understanding the challenges of negative MRI, FDG PET abnormalities, and SEEG evaluation
- The surgical possibilities and limitations in difficult to operate regions of the brain
CPD learning accredited.
We would like to thank our sponsor UCB Pharma Ltd for their support of this webinar.
Please note that the scientific programme and content has not been influenced in any way by sponsor.
Join in the conversation online using #RSMLive
Follow us on Twitter: @RoySocMed